Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHA2 | P29317 | 2/20 | 0.51 |
| ▸ | NTSR1 | P30989 | 17/20 | 0.47 |
| ▸ | NTSR2 | O95665 | 16/20 | 0.47 |
| ▸ | SORT1 | Q99523 | 16/20 | 0.47 |
| ▸ | KDM1A | O60341 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | KDM5A | P29375 | 1/20 | 0.43 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9807256 | 0.83 | EPHA2 (0.59) | EPHA2NTSR1NTSR2SORT1KDM1A | |
| SCHEMBL9807245 | 0.83 | EPHA2 (0.61) | EPHA2NTSR1NTSR2SORT1 | |
| SCHEMBL8969918 | 0.80 | EPHA2 (0.49) | EPHA2NTSR1NTSR2SORT1KDM1A | |
| SCHEMBL10378224 | 0.79 | EPHA2 (0.48) | EPHA2NTSR1NTSR2SORT1KDM1A | |
| SCHEMBL10378950 | 0.79 | EPHA2 (0.48) | EPHA2NTSR1NTSR2SORT1KDM1A | |
| SCHEMBL29980542 | 0.78 | EPHA2 (0.59) | EPHA2NTSR1NTSR2SORT1KDM1A | |
| SCHEMBL8970642 | 0.78 | EPHA2 (0.47) | EPHA2NTSR1NTSR2SORT1KDM1A | |
| SCHEMBL29379857 | 0.78 | SLC6A2 (0.60) | EPHA2NTSR1NTSR2SORT1 | |
| SCHEMBL9551316 | 0.77 | EPHA2 (0.59) | EPHA2NTSR1NTSR2SORT1 | |
| SCHEMBL9807306 | 0.77 | EPHA2 (0.62) | EPHA2KDM1AMAOBKDM5AKDM1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0146266-B1 | ENZYME-RESISTANT IMMUNOMODULATORY PEPTIDES | ORTHO PHARMACEUTICAL CORPORATION (US) | 1991-05-22 | — | — | EP | disclosed |